Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Angiography at RSNA

This article was originally published in Clinica

Executive Summary

Colour Doppler ultrasound, CT and holographic MR angiography could replace X-ray angiography as the standard of reference for carotid disease evaluation, said researchers speaking at RSNA. Researchers from the New England Baptist hospital, Boston, said they found a combination of ultrasound and MR to be extremely effective at detecting atherosclerotic disease at the carotid artery bifurcation in a prospective 25-patient study. Both were accurate and, in 23 of the patients concordant. The MRI images provided a good "road map and thus obviated the need for angiography," said Dr Steven Wetzner.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT094456

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel